Immuneering (IMRX) Goodwill (2021 - 2026)

Immuneering's Goodwill history runs 6 years deep, the most recent figure standing at $6.7 million for Q1 2026.

• In Q1 2026, Goodwill changed 0.0% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (changed 0.0% YoY), while the FY2025 annual figure was $6.7 million, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $6.7 million, roughly flat from $6.7 million in the prior quarter.
• The five-year high for Goodwill was $6.7 million in Q1 2022, with the low at $6.7 million in Q1 2022.
• The 5-year median for Goodwill is $6.7 million (2022), against an average of $6.7 million.
• The sharpest annual moves came in 2022 and 2023: Goodwill retreated 0.17% in 2022, then changed 0.0% in 2023.
• Immuneering's Goodwill stood at $6.7 million in 2022, then changed by 0.0% to $6.7 million in 2023, then changed by 0.0% to $6.7 million in 2024, then changed by 0.0% to $6.7 million in 2025, then changed by 0.0% to $6.7 million in 2026.
• Business Quant data shows IMRX's Goodwill at $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $6.7 million in Q3 2025.